# Preventing Squamous Cell Skin Cancer

> **NCT02347813** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 12 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Skin

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT02347813
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02347813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02347813, "Preventing Squamous Cell Skin Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02347813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*